The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laufer, T. M.
Right arrow Articles by Glimcher, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laufer, T. M.
Right arrow Articles by Glimcher, L. H.

The Journal of Immunology, Vol 159, Issue 12 5914-5920, Copyright © 1997 by American Association of Immunologists


ARTICLES

Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation

TM Laufer, ST Smiley, A Ranger, VK Clements, S Ostrand-Rosenberg and LH Glimcher
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.

Class II MHC molecules are heterodimeric transmembrane glycoproteins that function in the presentation of Ag to CD4+ T cells. Deletion of the cytoplasmic domains of the murine class II A alpha- and A beta- chains has previously been shown to diminish Ag presentation and abrogate rejection of class II-transfected tumor cells. To examine the contributions of individual amino acid residues of the A beta cytoplasmic domain to Ag presentation and tumor rejection, we have produced a series of cell lines expressing A beta class II molecules with site-directed mutations. An A beta(k) cDNA was constructed with mutations in the five conserved amino acid residues, Q224, K225, L235, L236, and Q237 (delta5). In addition, cDNA were produced in which alanine was individually substituted for A beta(k) cytoplasmic domain residues 224 through 237 or doubly substituted at residues G226 and P227 or L235 and L236. These mutant cDNAs were individually cotransfected with wild-type A alpha cDNA into the class II-negative M12.C3 B lymphoma and Sal sarcoma cell lines. As was previously reported for transfectants lacking the entire A beta(k) cytoplasmic domain, the delta5 M12.C3 transfectant could not effectively present Ag to an autoreactive Ak-restricted T cell hybrid, and the delta5 Sal transfectant was not rejected when inoculated into syngeneic hosts. A finer analysis revealed that alteration of the individual residue Q224 or the two residues G226 and P227 abrogated Ag presentation in vitro, while mutation of G226 diminished tumor rejection in vivo. Thus, the function of the A beta cytoplasmic domain in Ag presentation both in vitro and in vivo can be disturbed by mutation of single amino acid residues.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. El Fakhry, M. Bouillon, C. Leveille, A. Brunet, H. Khalil, J. Thibodeau, and W. Mourad
Delineation of the HLA-DR Region and the Residues Involved in the Association with the Cytoskeleton
J. Biol. Chem., April 30, 2004; 279(18): 18472 - 18480.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Becart, N. Setterblad, S. Ostrand-Rosenberg, S. J. Ono, D. Charron, and N. Mooney
Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-dependent signaling
J. Cell Sci., June 15, 2003; 116(12): 2565 - 2575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bouillon, Y. El Fakhry, J. Girouard, H. Khalil, J. Thibodeau, and W. Mourad
Lipid Raft-dependent and -independent Signaling through HLA-DR Molecules
J. Biol. Chem., February 21, 2003; 278(9): 7099 - 7107.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Matsuoka, H. Tabata, and S. Matsushita
Monocytes Are Differentially Activated Through HLA-DR, -DQ, and -DP Molecules Via Mitogen-Activated Protein Kinases
J. Immunol., February 15, 2001; 166(4): 2202 - 2208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.